Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 5:46 pm Purchase | 2024-09-30 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | EcoR1 Capital, LLC | 4,288,120 4.800% | 132,745 (+3.19%) | Filing History |
| 2024-11-14 5:43 pm Sale | 2024-09-30 | 13G | Centessa Pharmaceuticals plc CNTA | EcoR1 Capital, LLC | 3,223,851 2.900% | -2,394,928 (-42.62%) | Filing History |
| 2024-10-08 4:35 pm Purchase | 2024-10-06 | 13D | Galapagos N.V. GLPG | EcoR1 Capital, LLC | 7,094,049 10.770% | 588,159 (+9.04%) | Filing History |
| 2024-09-03 5:51 pm Purchase | 2024-08-23 | 13G | Whitehawk Therapeutics Inc WHWK | EcoR1 Capital, LLC | 1,845,253 7.500% | 1,845,253 (New Position) | Filing History |
| 2024-08-23 4:01 pm Unchanged | 2024-08-19 | 13D | Galapagos N.V. GLPG | EcoR1 Capital, LLC | 6,505,890 9.900% | 0 (Unchanged) | Filing History |
| 2024-08-16 12:07 pm Purchase | 2024-08-14 | 13D | AnaptysBio, Inc. ANAB | EcoR1 Capital, LLC | 7,794,996 25.800% | 274,572 (+3.65%) | Filing History |
| 2024-07-01 4:39 pm Purchase | 2024-06-20 | 13G | Tectonic Therapeutic, Inc. TECX | EcoR1 Capital, LLC | 849,143 5.800% | 849,143 (New Position) | Filing History |
| 2024-05-31 5:25 pm Purchase | 2024-05-22 | 13G | HOOKIPA Pharma Inc. HOOK | EcoR1 Capital, LLC | 571,732 5.900% | 112,230 (+24.42%) | Filing History |
| 2024-05-03 5:02 pm Purchase | 2024-04-23 | 13G | Morphic Holding, Inc. MORF | EcoR1 Capital, LLC | 3,014,752 6.000% | 2,803,490 (+1327.02%) | Filing History |
| 2024-04-08 2:46 pm Purchase | 2024-03-21 | 13G | LENZ Therapeutics, Inc. LENZ | EcoR1 Capital, LLC | 1,219,774 4.800% | 1,219,774 (New Position) | Filing History |
| 2024-03-26 11:59 am Purchase | 2024-03-08 | 13G | Adaptimmune Therapeutics plc ADAP | EcoR1 Capital, LLC | 164,424,420 10.700% | 51,000,000 (+44.96%) | Filing History |
| 2024-03-11 3:34 pm Purchase | 2024-02-28 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | EcoR1 Capital, LLC | 4,155,375 5.300% | 4,155,375 (New Position) | Filing History |
| 2024-02-22 7:01 pm Unchanged | 2024-02-22 | 13D | Zymeworks Inc. ZYME | EcoR1 Capital, LLC | 14,132,291 19.990% | 0 (Unchanged) | Filing History |
| 2024-02-16 12:54 pm Purchase | 2024-02-05 | 13G | iTeos Therapeutics, Inc. ITOS | EcoR1 Capital, LLC | 1,944,672 5.400% | 1,944,672 (New Position) | Filing History |
| 2024-02-15 11:38 am Unchanged | 2023-12-31 | 13G | Morphic Holding, Inc. MORF | EcoR1 Capital, LLC | 211,262 0.400% | 0 (Unchanged) | Filing History |
| 2024-02-15 11:35 am Unchanged | 2023-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | EcoR1 Capital, LLC | 6,995,861 8.400% | 0 (Unchanged) | Filing History |
| 2024-02-15 09:15 am Unchanged | 2023-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | EcoR1 Capital, LLC | 6,995,861 8.400% | 0 (Unchanged) | Filing History |
| 2024-02-14 8:02 pm Purchase | 2023-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | EcoR1 Capital, LLC | 6,995,861 8.400% | 811,000 (+13.11%) | Filing History |
| 2024-02-14 7:54 pm Sale | 2023-12-31 | 13G | Morphic Holding, Inc. MORF | EcoR1 Capital, LLC | 211,262 0.400% | -3,740,304 (-94.65%) | Filing History |
| 2024-02-14 6:59 pm Purchase | 2023-12-31 | 13G | Zymeworks Inc. ZYME | EcoR1 Capital, LLC | 14,132,291 19.990% | 694,818 (+5.17%) | Filing History |